Hsp in 80 years female management
"IgA vasculitis" AND elderly AND management
"Henoch-Schonlein purpura" AND adult AND "older" AND treatment
PMID: 41655840

| Feature | Detail |
|---|---|
| Skin biopsy | Leukocytoclastic vasculitis + IgA deposits on direct immunofluorescence |
| Urinalysis | Microscopic hematuria, proteinuria (>1 g/day = high-risk marker) |
| Serum IgA | Elevated in ~50%; non-specific |
| Complement | Normal C3/C4 (helps exclude SLE/MPGN) |
| Renal biopsy | Indicated if significant proteinuria (>1 g/day), rising creatinine, or nephrotic syndrome |
| Screen for underlying malignancy | Critical in elderly - HSP in adults >60 years may be a paraneoplastic manifestation (solid organ tumors: lung, GI, prostate) |
| Severity | Features | Management |
|---|---|---|
| Mild | Microscopic hematuria only, protein <0.5 g/day | Supportive; close urinalysis monitoring for 6 months |
| Moderate | Proteinuria 0.5-3 g/day, stable creatinine | RAAS blockade (ACEi or ARB); consider prednisolone course |
| Severe | Nephrotic syndrome (protein >3.5 g/day), rising creatinine, crescents on biopsy | Pulse IV methylprednisolone → oral prednisolone; consider add-on immunosuppression |
| Rapidly progressive | Crescent GN, rapidly rising creatinine | High-dose steroids ± cyclophosphamide (use with caution in elderly) |
| Concern | Management Adjustment |
|---|---|
| Corticosteroid side effects | High risk of osteoporotic fracture, hyperglycemia, delirium, infection; prescribe the lowest effective dose with PPI; add calcium + vitamin D; consider bone protection with bisphosphonate |
| Renal dosing | Most elderly have reduced eGFR at baseline; adjust all drug doses accordingly; avoid nephrotoxic agents |
| Infection risk | Immunosuppression (steroids, cyclophosphamide) carries high infection mortality in elderly; screen for TB, hepatitis B before starting |
| Malignancy screening | Age-appropriate cancer screening is essential - HSP can be paraneoplastic in elderly patients; treat the underlying malignancy |
| Polypharmacy / drug interactions | Review all medications; RAAS blockers may cause hyperkalemia with common drugs in elderly; cyclosporine has numerous interactions |
| Frailty / falls | Purpura + edema increase fall risk; physiotherapy referral |
| Monitoring | Urinalysis, serum creatinine, blood pressure, and urine protein:creatinine ratio at 1, 3, and 6 months; renal abnormalities may appear up to 6 months after initial presentation |
80-year-old female with HSP
├── ALWAYS: Screen for underlying malignancy
├── Skin only → Colchicine or Dapsone; supportive care
├── Joint pain → Paracetamol ± short-course steroids
├── GI pain/bleeding → Prednisolone 1 mg/kg/day + PPI
└── Renal involvement?
├── Urine protein <1 g/day + normal creatinine → RAAS blockade + monitor
├── Protein >1 g/day or rising creatinine → Renal biopsy + steroids ± RAAS
└── Nephrotic/crescentic → High-dose steroids ± cyclosporine/IVIG
(Avoid cyclophosphamide unless absolutely necessary in elderly)
Duration of treatment of steroids in case of hsp in skin gi and joint pain
"IgA vasculitis" AND corticosteroid AND duration AND treatment
PMID: 40183803
"Henoch-Schonlein purpura" AND corticosteroid AND "randomized" AND treatment
| Aspect | Detail |
|---|---|
| Role of steroids | Not indicated for skin lesions alone |
| Evidence | Harrison's 22e explicitly states steroids "have not proved beneficial in the treatment of skin disease" |
| Alternative | Colchicine 0.6 mg twice daily OR Dapsone 50-200 mg/day if treatment needed |
| Natural course | Lesions fade spontaneously within 5-14 days; new crops may appear for weeks |
Steroids should not be started for purpura alone - this is a common clinical error.
| Aspect | Detail |
|---|---|
| Role of steroids | Effective at reducing joint pain but not the first choice |
| First-line | Paracetamol (acetaminophen) - safest, especially in elderly |
| When steroids used | Only for severe, incapacitating arthralgias not controlled by analgesics |
| Dose | Prednisolone 1 mg/kg/day (max 60 mg/day) |
| Duration | Short course only - benefit expected within days; no need to continue beyond symptom control |
| Harrison's 22e | Prednisone "has been shown to be useful in decreasing tissue edema and arthralgias" |
NSAIDs (ibuprofen, naproxen) are effective for joint pain in younger patients but should be avoided in elderly due to GI/renal risk.
| Aspect | Detail |
|---|---|
| Dose | Prednisolone 1 mg/kg/day (max 60-80 mg/day) orally |
| Duration | 2 weeks of treatment, followed by a 2-week taper (total ~4 weeks) |
| Taper schedule | Week 1-2: Full dose → Week 3-4: Gradual dose reduction |
| Response | Corticosteroids are more effective than analgesics alone for abdominal pain |
| Severe/refractory GI | IV methylprednisolone pulse 500-1000 mg/day × 3 doses, then oral |
| Caution | Steroids do NOT prevent nephritis even when given for GI symptoms |
"Prednisone 1.0 mg/kg/day for 2 weeks followed by a 2-week taper can attenuate joint and GI symptoms."
Early discontinuation within 7 days (vs. 17.5 days standard) reduced total steroid dose without increasing complications, with 27% requiring readministration - but all resolved. This supports using the shortest effective course, especially important in an 80-year-old female.
| Organ | Steroid Needed? | Dose | Duration | Taper? |
|---|---|---|---|---|
| Skin only | No | - | - | - |
| Joints (mild-moderate) | No - use paracetamol | - | - | - |
| Joints (severe) | Yes | 1 mg/kg/day (max 60 mg) | 1-2 weeks | Rapid taper over 1-2 weeks |
| GI pain (moderate-severe) | Yes | 1 mg/kg/day (max 60 mg) | 2 weeks | 2-week taper (total 4 weeks) |
| Severe GI / refractory | Yes | IV methylprednisolone 500-1000 mg × 3 days | 3 days IV, then oral for 2 weeks | 2-week taper |
| Renal disease | Controversial | 1 mg/kg/day | Up to 6 months | Slow taper over months |